Joining the Dots Teenagers and Young Adults October 2025- On Demand

In this talk, listen to Dr. Mohring discuss how to make sense of the ADHD brain by weaving together neuroscience, clinical insight, and real‑world experience.

Discover what the latest data reveals about ADHD treatment drop-off—and why it matters. Professor Ian Wong shares an overview of recent data and new insights into why patients discontinue medication, the clinical impact of staying on treatment, and discusses tips to improve adherence.

Dr. Joe Johnson provides an evidence-based overview of pharmacological treatment options for adult ADHD, focusing on why stimulants are typically first choice, what major analyses and guidelines suggest, and how to translate this evidence into practical treatment decisions in ADHD care.

Sarah Morris and Dr. Judith Mohring lead a case-based session exploring why ADHD is often missed or diagnosed late in girls and women, and what that means for outcomes. 

Dr. Christopher Abbott leads a practical session on how to support adolescents with ADHD to maintain effective care into adulthood.  He explores why transition so often fails despite symptom persistence, highlights the real-world prescribing “drop-off” around ages 16–18, and shares actionable tools to improve continuity of care.

Follow Professor Peter Hill as he explores how ADHD symptoms can manifest from adolescence to adulthood (16–26). The complexities that come with this transition are detailed as well as practical advice to support a more effective transition into adulthood.

In this talk, listen to Dr Mischa Mockett and Dr Joe Johnson explore the complex overlap between ADHD and intellectual disabilities, offering a clinically grounded and highly practical guide for recognising, diagnosing, and managing ADHD in individuals with varying levels of cognitive impairment.